STML
T. Rowe Price Associates’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-176,795
| Closed | -$1.84M | – | 2563 |
|
|
2019
Q3 | $1.84M | Sell |
176,795
-582,570
| -77% | -$6.06M | ﹤0.01% | 1593 |
|
|
2019
Q2 | $11.6M | Sell |
759,365
-133,221
| -15% | -$2.04M | ﹤0.01% | 1288 |
|
|
2019
Q1 | $11.5M | Buy |
+892,586
| New | +$11.5M | ﹤0.01% | 1295 |
|
|
2014
Q4 | – | Sell |
-54,473
| Closed | -$679K | – | 2574 |
|
|
2014
Q3 | $679K | Sell |
54,473
-38,719
| -42% | -$483K | ﹤0.01% | 1829 |
|
|
2014
Q2 | $1.37M | Sell |
93,192
-737,074
| -89% | -$10.8M | ﹤0.01% | 1652 |
|
|
2014
Q1 | $16.9M | Sell |
830,266
-46,400
| -5% | -$945K | ﹤0.01% | 1159 |
|
|
2013
Q4 | $17.2M | Sell |
876,666
-47,500
| -5% | -$931K | ﹤0.01% | 1140 |
|
|
2013
Q3 | $41.9M | Sell |
924,166
-6,034
| -0.6% | -$273K | 0.01% | 881 |
|
|
2013
Q2 | $22.2M | Buy |
+930,200
| New | +$22.2M | 0.01% | 1039 |
|